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Introduction
Bronchial asthma is one of the commonest
diseases that affects both adults and children. It
has profound medical and social implications in
terms of its morbidity and mortality and loss of
productive working hours. The prevalence of
asthma is increasing worldwide. The mortality and
morbidity from asthma appear to be increasing
despite changes in medical practice and advances
in the treatment of asthma over the years!,2.3.
Most deaths related to asthma are due to relatively
acute attacks, usually with a background of poorly
controlled asthma. Deaths and morbidity have
been associated with over reliance on
bronchodilators. It has been shown that both
patients and doctors prefer a quick acting
bronchodilator for its symptomatic efficacy for
maintenance treatment of asthma in those who
present with acute attack4• Oral salbutamol,
despite its extremely poor clinical efficacy, is also
commonly prescribed5,6. Worldwide, studies had
shown an under utilization of inhaled steroid for
asthma prevention4,5,6,7,8,9,IO. Short courses of oral
steroid for patients with acute exacerbation of
asthma were also shown to be under prescribed6,7.
All these contribute to poor asthma control.
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It is important to follow up patients with asthma
regularlyll. These visits have positive effects on
promoting periodic evaluation and review of
asthma severity and treatment. The physician can
monitor patient's lung function, improve
compliance and proficiency of drug usage as well
as educate patients and parents about preventive
measures such as reducing exposure to allergens
and irritants. Referral to an asthma specialist clinic
after an acute attack of asthma in the emergency
room visit appears to reduce asthma relapses and
improve asthma outcome12 • However, many
asthmatic patients depend on the Emergency
department for ad hoc asthma care, and are not
properly followed up and reviewed in the primary
care or specialist clinics 3,14,15. Ordonez GA et al
showed that 40% of children with frequent
episodic and persistent asthma did not have a
regular medical reviewl6 . Many patients who
received acute care for asthma in the emergency
department had previous attacksI7,18,19.
Dependence on the emergency department by
frequent attenders may serve as a barrier to
ongoing medical care provided by general
practitioners or specialists in the community and
may result in increased risk of poor control of the
disease and admissionI3,14,2o.
Hence, this study aimed to examine prior asthma
control and medical care of patients who attended
the Accident and Emergency department with an
acute asthmatic attack in order to gain an insight
on the current status of this group of high risk
patients.
Materials and Methods
This was a descriptive cross sectional study
conducted at the emergency department of
University of Malaya Medical Centre (UMMC),
Kuala Lumpur. All patients above 12 years old who
presented with acute exacerbation of bronchial
asthma requiring nebuliser treatment were
recruited. Patients with chronic obstructive
pulmonary disease, whose diagnosis of asthma
was uncertain or those with severe asthma
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needing immediate resuscitation and admission
were excluded.
The study was conducted over a two-week period
in July 2001 on a 24 hour basis by the investigator
and a research assistant (RA) on consecutive
patients. A face to face interview with a structured
questionnaire was carried out. The questionnaire
was constructed from a review of literature
followed by discussion with peers and specialists
in the field of asthma care for construct and face
validity. It was piloted to ensure internal
consistency between the investigator and the RA.
Data Analysis: Data collected was analysed using
SPSS version 10.0. Unpaired student's t-tests were
used to compare continuous variables; Chi-
squared test and Fisher exact test were used to test
for differences between proportions. P<0.05 was
taken as the significance level.
Delmitions: In this study, asthma severity is
classified according to the American National
Asthma Education and Prevention Programme
(NAEPP), report II 1997 (see Table I). Patients with
poorly controlled asthma are defined as those with
two or more visits to the emergency department
for acute attacks in the past 6 months and those
with symptoms more than twice per week (NAEPP
step 2 and above).
Results
Demographic data of the study population
A total of 70 asthmatic patients, 25 (36%) men and
45 (64%) women were recruited. The mean age of
the patients was 42 years (range 12-80 years).
There were 31 (45%) Malay, 15 (21%) Chinese, 23
(33%) Indians and 1 (l%) of other race. The mean
duration of asthma was 16 C±6) years.
Hospitalization and emergency room visits
In the preceding six months, 17 (24.3%) patients
had been hospitalized and the average number of
hospitalizations was 0.4 times (range 0-4). There
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was 5 (7.1%) patients who had experienced near-
fatal or life-threatening exacerbations in the past
one-year. Forty-one (58.6%) of them had visited
the e!fiergency room 2: 2 times in the past 6 months
for acute exacerbations. The average emergency
room visits was 05.7 times (range 0-60) in the
previous six months.
Severity of asthma
Using the NAEPP classification of asthma severity,
24 (34%), 12 (17%), 15 (21%) and 19 (27%) patients
were in step 1,2,3,4 of asthma severity
respectively. Forty-six (66%) patients belonged to
step 2 or higher in severity and were considered
poorly controlled. Another 5 patients were in step
1 but had 2: 2 visits to the emergency room in the
past 6 months for acute asthma and were
considered to have poorly controlled disease.
Overall, 51(73%) patients had poorly controlled
asthma as defined by our methodology.
Demographic data of patients with good and
poor control of asthma
Table II showed that the mean age of patients in
the poorly controlled group was higher than those
with good control of asthma. However, there was
no significant difference found in the age, sex,
race, duration of disease and smoking status
between these two groups.
Current Asthma Medication
Table III shows the medication patients received
prior to the current emergency room visits. The
majority of patients were using inhaled salbutamol
via metered-dose inhalers (MDI). Less than half of
the patients were using inhaled corticosteroids
(ICS), via MD!. Half of the study population was
taking oral medication regularly. Salbutamol was
the most frequently prescribed oral medication
(30%).
A third of the patients had one or more courses of
oral prednisolone in the past 6 months for acute
exacerbations. None were on regular oral steroid.
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Relationship between regular drug treatment
and asthma severity
Figure 1 shows the relation between regular drug
treatment and severity of asthma. About half of the
patients in step 2 and 4, and two-thirds in step 3
received inhaled corticosteroids. Fifty-eight
percent of patients in step 4 and 30% of patients in
step 3 received 'add-on' medication such as slow-
release theophylline or long acting beta agonist
(some patients were on both oral theophylline and
inhaled long acting ~-agonist). However, 40% of
patients in Step 3 and 4 were using regular oral
short acting beta-agonist.
Overall, 28 (40%) patients were not recelvmg
appropriate treatment according to the steps of
asthma severity as per Malaysian Thoracic Society
guidelines on management of adult asthma".
Among the 51 patients with poorly controlled
asthma, 22 (43.1%) were not on regular preventive
treatment with inhaled steroids and 35 (68.6%)
were not receiving " add-on" medication.
Follow-up clinics
Thirty-two (46%) patients did not receive follow
up for their asthma. Among the 38 (54%) who had
regular follow-up, 17 (44%), 5 (13%), 6 (16%), 5
(13%),4 (11%) and 1 (3%) were followed up at the
asthma clinic, general out patient clinic of UMMC,
private GP, health clinics, other hospital and family
physicians respectively. The average interval of
follow-up was 2.5 months (range weekly to 6
monthly).
Relationship ofasthma control and follow-up
The majority of patients in step 2 and 3 of asthma
severity had regular follow-up but of those in step
4, only half of them had regular follow-up. More
than half of those in step 1 were also not followed
up. A significant greater number of patients with
poorly controlled asthma received regular follow
up as compared to those with good control
(p<O.OI). All patients who were followed up at the
asthma clinic received inhaled corticosteroids.
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Table I: The NAEPP classification of Asthma Severity
Step 4
Severe
Persistent
Step 3
Moderate
Persistent
Step 2
Mild
Persistent
Step 1
Mild
intermittent
Symptoms
Continual symptoms
Limited physical activity
Frequent exacerbation
Daily symptoms
Daily use of inhaled short-acting
beta-2-agonist
Exacerbation affect activity
Exacerbation.::: 2 times a week
May last days
Symptoms> 2 times a week
Exacerbation may affect activity
Symptoms ~ 2 times a week
Asymptomatic and normal PEF
between exacerbation. Exacerbation brief (from a few
hours to a few days) intensity may vary
Night-time symptoms
Frequent
> 1 time a week
> 2 times a month
~ 2 times a month
NAEPP: American National Asthma Education and Prevention Programme, report II 1997
Table II: Demographic data of patients with good and poor control of asthma
Good control (n: 19) Poor control (n: 51) P- value
Mean age 36.00 years (±19.83) 44.53 years (± 18.15) 0.093
Mean duration of disease 15.26 years l±10.97) 16.99 years (±12.41 ) 0.59
Sex Male 7 (37%) 18 (35%) 1.00
Female 12 (63%) 33 (65%)
Race Malay 7(37%) 24 (47%) 0.58
Chinese· 6 (32%) 9 (18%)
Indian 6 (32%) 17 (18%)
Others o (O%) 1 (2%)
Smoking Yes 10 (53%) 27 (53%) 1.00
status No 9 (47%) 24 (47%)
(active or passive)
Med J Malaysia Vol 58 No 4 October 2003 485
ORIGINAL ARTiClE
Table III: Current Asthma Medication
Medications
MDI Salbutamol
MDI corticosteroid
Inhaled Long acting ~-agonist
Oral Medication
Salbutamol
Theophylline
'Prednisolone
Home nebuliser
Oral hydroxychloroquine
Monteleukast
Number
57
32
5
35
21
16
27
2
1
1
%
81.4
45.7
7.5
50
30
22.9
38.6
0.03
0.01
0.01
• One or more course of oral prednisolone in the past 6 months
MDI: metered dose inhaler
100
90
80
70
Percentage 60
of patients 50
on
medication 40
30
20
10
0
52.6 52.6
Step 1 Step 2 Step 3 Step 4
severity of asthma
'some patients were on both oral theophylline and inhaled long acting ~-agonist.
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Discussion
About two third of the patients studied had poorly
controlled asthma. This figure is similar to studies
done using similar criteria in the emergency room
in Singapore where 63% of patients were found to
belong to this group5. Another study done in
polyclinics in Singapore found 54% of patients
belonging to this group4.
This study revealed a high proportion of patients
in step 3 and 4 of asthma severity. 24.3% of
patients had been hospitalized and 58.6% had
frequent emergency room visit in the previou's six
months with an average emergency room visit of
about 6 times, As a fair number of the study
population was followed up at the asthma clinic in
UMMC, their disease could have been more severe
and they could have poorer control of their
disease. During the study period, there was also a
problem with haze in Kuala Lumpur that might
have resulted in more severe symptoms in these
patients.
Most patients were using regular inhaled
salbutamol for its symptomatic efficacy'. Oral
salbutamol was utilised by a third of these patients
and was the most commonly prescribed oral
medication despite its poor clinical efficacy. Over
reliance on inhaled and oral short acting beta
agonists by both doctors and patients may have
negative consequences on asthma control. It may
result in a delay in instituting prophylactic
therapy'. The NAEPP guidelines suggest that if a
beta agonist is used more than twice per week, it
is an indication for the introduction or an increase
in the dose of a prophylactic therapy21.
The role of inhaled corticosteroids in the long-term
preventive treatment of asthma is important. The
Malaysian guidelines on the management of adult
asthma and the NAEPP guidelines recommend
inhaled corticosteroid therapy to be used as a first
choice in preventive treatment of asthma21,22. In
this study, 46% of patients were using inhaled
corticosteroid and among patients with poor
control of the disease, 57% were on them. This
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finding is similar to studies done worldwide 4.5,6,7.8.9,10
and locally23,24 where there is still an
underutilization of inhaled steroids. However,
comparing to studies done in the emergency
department in Muar6 and Singapore5, where only
10% and 23% respectively of their patients were on
inhaled steroids, more patients were receiving
inhaled steroids. There appears to be an increase
in awareness among the doctors in its usage,
taking into account the number of patients on
follow up with the specialist clinic.
Among the poorly controlled group, although 57%
of them were on regular inhaled corticosteroid,
they were still experiencing recurrent attacks. This
could be due to non-compliance, under-dosage,
ineffective delivery of the drug through poor
inhaler technique or poor steroid responsiveness
and a need for the stepped up therapy. Other
factors could be ineffective patient management
where their severity of asthma had not been
properly reviewed and their drug dosage not
stepped up accordingly. These factors were
beyond the scope of this study but would be
interesting to look at in future.
A Cochrane review had found that a short course
of corticosteroids significantly reduced the number
of relapses to additional care and decreases beta
agonist use without an apparent increase in side
effects for patients with acute exacerbation of
asthma25. The NAEPP guidelines and Malaysia
guidelines on Asthma management also suggest
that, a short course of systemic corticosteroids can
reverse an otherwise refractory asthma
exacerbation and preclude the need for
emergency care and possible hospitalization21,22. In
this study 38.6% of the patients were given one or
more short course of corticosteroids in the past six
months for acute exacerbation of asthma.
The NAEPP guidelines and Malaysian guidelines of
asthma management recommended that "add on"
medication should be considered in patients with
a severity of step 3 or higher21,22. Oral slow release
theophylline was the main "add on" medication
used as it is cheap and cost effective. Other "add
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on" medications are oral or inhaled long acting
beta agonists. Oral theophylline was prescribed to
22.9<% of patients and inhaled long acting beta-
agonist was only prescribed to 7.5% of patients.
Some of these patients were on both medications.
It is surprising to find that only a third of the poorly
controlled group were on "add on" medications
but 40% of patients in step 3 and 4 were given
regular oral short acting beta-agonist which was
inappropriate.
It appears that there was still a failure among the
doctors in following the stepwise approach in
asthma management. Forty percent of patients did
not receive appropriate treatment. This pattern of
under treatment reflects the lack of emphasis on
long-term preventive treatment. The practice of
prescribing regular oral Salbutamol as a 'reliever'
should be discouraged. Patients' over reliance on
short acting beta-agonists reflects poor patient
education and their physician may not have
offered them action plans for management of
acute exacerbation. It appears that evidence based
approach to asthma management is still lacking
and continuous medical education is needed.
Doctors need to be trained and updated so that
they are familiar with the proper asthma
management guidelines.
Almost half the study population and 35% of the
poorly controlled patients did not have regular
follow up. This is disappointing as it has been
shown that regular follow up can promote better
patient carel1 . The arrangement for follow up after
an acute exacerbation of 'asthma was inadequate
as is shown in other study15. As asthma is a chronic
condition, it needs ,regular evaluation and
monitoring to ensure proper treatment,
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compliance and drug proficiency. Therefore,
protocols must be implemented at the emergency
department to ensure that these patients are
followed up and referred to the asthma clinic or
their own general practitioners when appropriate.
The goal one strives to achieve as was in the GINA
asthma management programme 2002 26 will be no
emergency visits at all for these patients.
This study has been limited by a small sample size.
However, it does give an indication of the current
state of asthma management in the emergency
department. An awareness of the weakness and
shortcomings faced will hopefully bring about
strategic planning and change for better patient
care.
Conclusion
Patients' asthma control and follow up have been
sub-optimal in those presenting with acute
exacerbation at the emergency department. There
was an over reliance on short acting beta agonist
for acute symptomatic relief and an under-usage of
preventive treatment. As the emergency
department plays an active role on asthma
management, it is essential that asthma protocol
and appropriate referral of follow up care be
instituted for all patients with asthma.
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